tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

RxSight sees FY24 revenue $139M-$140M, consensus $139.64M

Gross margin in the range of 70% to 71%, up from previous guidance range of 68% to 70%; and Operating expenses at the low end of its previously provided guidance range of $135.0 to $136.0 million, including non-cash stock-based compensation expense, now also expected at the lower end of the previous guidance range of $29.0 to $30.0 million.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1